Angiocrine Bioscience
Launch date
Employees
Market cap
-
Enterprise valuation
$232—349m (Dealroom.co estimates Oct 2021.)
New York City New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $4.0m | Early VC | |
N/A | $58.1m | Early VC | |
* | $15.0m | Grant | |
Total Funding | $77.1m |
Recent News about Angiocrine Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.